Streetbeat News

Analyst Ratings

DELL

Analysts have provided various ratings for Dell Technologies (NYSE:DELL) within the last quarter, with a total of 7 bullish, 7 somewhat bullish, 1 indifferent, and 1 somewhat bearish. The average price target for Dell Technologies over the next 12 months is $67.62, an increase of 17.17% from the previous average price target of $57.71.

Portfolio Pulse from Benzinga Insights

September 25, 2023 | 8:00 pm

WULF

TeraWulf (NASDAQ:WULF) has received positive analyst ratings in the last quarter, with 3 bullish and 6 somewhat bullish ratings. The average 12-month price target for the stock is $4.03, a 0.75% increase from the previous target of $4.00.

Portfolio Pulse from Benzinga Insights

September 25, 2023 | 8:00 pm

BITF

Over the past 3 months, 7 analysts have published their opinion on Bitfarms (NASDAQ:BITF) stock, with an average price target of $2.86, implying an upside from the current price of $1.065. The current average has increased by 43.0% from the previous average price target of $2.00.

Portfolio Pulse from Benzinga Insights

September 25, 2023 | 8:00 pm

IMAB

Over the past 3 months, 5 analysts have published their opinion on I-MAB (NASDAQ:IMAB) stock, with 3 being bullish, 2 somewhat bullish, and none being bearish. The average 12-month price target for I-MAB is $23.0, a decrease of 6.12% from the previous average price target of $24.50.

Portfolio Pulse from Benzinga Insights

September 25, 2023 | 8:00 pm

PHVS

Wedbush has initiated coverage on Pharvaris N.V. (NASDAQ:PHVS) with an Outperform rating and a price target of $27. The analyst sees a 35% upside potential and highlights Pharvaris' strategy to develop oral therapeutic options for hereditary angioedema (HAE). The analyst's estimates are skewed toward PHVS416, an acute HAE therapy, with a projected launch by FY26 and FY30 revenue reaching $644 million. The clinical hold on the PHVS719 program is expected to be lifted, allowing for advancement to the prophylactic market.

Portfolio Pulse from Vandana Singh

September 25, 2023 | 7:47 pm

EQNR

Equinor's (NYSE:EQNR) short percent of float has fallen 10.53% since its last report, with 5.32 million shares sold short, which is 0.17% of all regular shares available for trading. This decrease in short interest could signal a more bullish market sentiment towards Equinor. Compared to its peers, Equinor has less short interest as a percentage of float, with an average of 1.63%.

Portfolio Pulse from Benzinga Insights

September 25, 2023 | 7:45 pm

AJG

Arthur J. Gallagher's (NYSE:AJG) short percent of float has risen 52.94% since its last report, with 2.44 million shares sold short, which is 1.3% of all regular shares available for trading. It would take traders 3.85 days to cover their short positions on average. The company's short interest is less than its peer group average of 3.26%.

Portfolio Pulse from Benzinga Insights

September 25, 2023 | 7:45 pm

ING

ING Groep's short percent of float has fallen 41.67% since its last report, with 2.61 million shares sold short, which is 0.07% of all regular shares available for trading. This decrease in short interest could signal a more bullish sentiment towards the stock. Compared to its peers, ING Groep has less short interest.

Portfolio Pulse from Benzinga Insights

September 25, 2023 | 7:45 pm

ANGO

MMSI

H.C. Wainwright initiated coverage on AngioDynamics Inc (ANGO) with a 'Buy' rating and a price target of $19, noting the company's debt-free status and significant undervaluation compared to peers. AngioDynamics, which generates over 80% of its revenue from the U.S., has substantial room for growth in the high-growth Med Tech segment. The company recently sold its Dialysis product portfolio and BioSentry Tract Sealant System Biopsy product to Merit Medical Systems Inc (MMSI) for $100 million.

Portfolio Pulse from Vandana Singh

September 25, 2023 | 7:34 pm

CRWD

A significant bearish stance has been taken on CrowdStrike Holdings (NASDAQ:CRWD) as evidenced by unusual options activity. The overall sentiment of big-money traders is split between 23% bullish and 76% bearish. Whales have been targeting a price range from $110.0 to $175.0 for CrowdStrike Holdings over the last 3 months. The price of CRWD is currently down -1.6% at $159.97. Analysts from Jefferies, Scotiabank, Truist Securities, and Cantor Fitzgerald have maintained their ratings on CrowdStrike Holdings with price targets ranging from $170 to $200.

Portfolio Pulse from Benzinga Insights

September 25, 2023 | 7:32 pm